Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Antirheumatic Agents"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 41-60 z 10174
Tytuł:
A case series on tofacitinib-induced weight gain.
Autorzy:
Shah K; Department of Pharmacology, Smt. NHL Municipal Medical College, Ahmedabad, Gujarat, India.
Shukla D; Department of Medicine, VS General Hospital, Ahmedabad, Gujarat, India.
Patel M; Department of Medicine, VS General Hospital, Ahmedabad, Gujarat, India.
Malhotra S; Department of Pharmacology, Smt. NHL Municipal Medical College, Ahmedabad, Gujarat, India.
Pokaż więcej
Źródło:
Indian journal of pharmacology [Indian J Pharmacol] 2023 Jul-Aug; Vol. 55 (4), pp. 263-265.
Typ publikacji:
Journal Article; Comment
MeSH Terms:
Arthritis, Rheumatoid*/drug therapy
Antirheumatic Agents*/therapeutic use
Drug-Related Side Effects and Adverse Reactions*
Humans ; Pyrroles/adverse effects ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Anti-TNF-α therapy induced psoriasis in rheumatoid arthritis patients according to FDA postmarketing surveillance data.
Autorzy:
Joulfayan H; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, USA.
Makunts T; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, USA.
Abagyan R; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Jun 27; Vol. 13 (1), pp. 10448. Date of Electronic Publication: 2023 Jun 27.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Antirheumatic Agents*/adverse effects
Arthritis, Rheumatoid*/drug therapy
Arthritis, Rheumatoid*/chemically induced
Psoriasis*/chemically induced
Psoriasis*/drug therapy
Adult ; Female ; Humans ; Middle Aged ; Antibodies, Monoclonal, Humanized/therapeutic use ; Chronic Disease ; Immunosuppressive Agents/therapeutic use ; Tumor Necrosis Factor Inhibitors/therapeutic use ; Tumor Necrosis Factor-alpha ; Male
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
An Initially Missed Diagnosis of Venous Thromboembolic Phenomenon in Adult-Onset Still's Disease: A Case Report and Literature Review.
Autorzy:
Mankgele M; Division of Internal Medicine, Faculty of Health Sciences, School of Clinical Medicine, University of Witwatersrand, Johannesburg, South Africa.
Hlawe D; Division of Internal Medicine, Faculty of Health Sciences, School of Clinical Medicine, University of Witwatersrand, Johannesburg, South Africa.
Fabiano Z; Division of Internal Medicine, Faculty of Health Sciences, School of Clinical Medicine, University of Witwatersrand, Johannesburg, South Africa.
Solomon A; Department of Rheumatology, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa.
Thomas R; Department of Pulmonology, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa.
Matyeshana M; Division of Nuclear Medicine, Faculty of Health Sciences, School of Clinical Medicine, University of Witwatersrand, Johannesburg, South Africa.
Mbakaza O; Department of Nuclear Medicine, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa.
Seboka M; Department of Rheumatology, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa.
Pokaż więcej
Źródło:
The American journal of case reports [Am J Case Rep] 2023 Jun 23; Vol. 24, pp. e939520. Date of Electronic Publication: 2023 Jun 23.
Typ publikacji:
Review; Case Reports; Journal Article
MeSH Terms:
Still's Disease, Adult-Onset*/complications
Still's Disease, Adult-Onset*/diagnosis
Antirheumatic Agents*/therapeutic use
Thromboembolism*/complications
Adult ; Female ; Humans ; Missed Diagnosis ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Peripheral blood cellular dynamics of rheumatoid arthritis treatment informs about efficacy of response to disease modifying drugs.
Autorzy:
Hedman ÅK; Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.; Department of Inflammation and Immunology, Pfizer, 1 Portland Street, Cambridge, MA, 02139, USA.
Winter E; CytoReason, Tel-Aviv, Israel.
Yoosuf N; Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.; Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden.
Benita Y; CytoReason, Tel-Aviv, Israel.
Berg L; Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
Brynedal B; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
Folkersen L; Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
Klareskog L; Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
Maciejewski M; Department of Inflammation and Immunology, Pfizer, 1 Portland Street, Cambridge, MA, 02139, USA.
Sirota-Madi A; CytoReason, Tel-Aviv, Israel.
Spector Y; CytoReason, Tel-Aviv, Israel.
Ziemek D; Department of Inflammation and Immunology, Pfizer, Berlin, Germany.
Padyukov L; Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
Shen-Orr SS; CytoReason, Tel-Aviv, Israel.; Technion-Israel Institute of Technology, Haifa, Israel.
Jelinsky SA; Department of Inflammation and Immunology, Pfizer, 1 Portland Street, Cambridge, MA, 02139, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Jun 21; Vol. 13 (1), pp. 10058. Date of Electronic Publication: 2023 Jun 21.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antirheumatic Agents*/therapeutic use
Arthritis, Rheumatoid*/drug therapy
Arthritis, Rheumatoid*/genetics
Arthritis, Rheumatoid*/diagnosis
Humans ; Leukocytes, Mononuclear/metabolism ; CD4-Positive T-Lymphocytes/metabolism ; RNA
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Encouraging visual outcomes in children with idiopathic and JIA associated uveitis: a population-based study.
Autorzy:
Siiskonen M; Department of Ophthalmology, Oulu University Hospital, Oulu, Finland.; Research Unit of Clinical Medicine, Oulu, Finland.; Medical Research Center, University of Oulu, Oulu, Finland.
Hirn I; Research Unit of Clinical Medicine, Oulu, Finland.; Medical Research Center, University of Oulu, Oulu, Finland.
Pesälä R; Research Unit of Clinical Medicine, Oulu, Finland.; Medical Research Center, University of Oulu, Oulu, Finland.
Ohtonen P; The Research Unit of Surgery, Anesthesia and Intensive care, Oulu University Hospital and University of Oulu, Oulu, Finland.; Research Service Unit, Oulu University Hospital, Oulu, Finland.
Hautala N; Department of Ophthalmology, Oulu University Hospital, Oulu, Finland. .; Research Unit of Clinical Medicine, Oulu, Finland. .; Medical Research Center, University of Oulu, Oulu, Finland. .; Research Unit of Clinical Medicine and MRC Oulu, Department of Ophthalmology, University of Oulu, Oulu University Hospital, Oulu, P.O.Box 21, 90029 OYS, Finland. .
Pokaż więcej
Źródło:
Pediatric rheumatology online journal [Pediatr Rheumatol Online J] 2023 Jun 15; Vol. 21 (1), pp. 56. Date of Electronic Publication: 2023 Jun 15.
Typ publikacji:
Journal Article
MeSH Terms:
Uveitis*/drug therapy
Uveitis*/epidemiology
Uveitis*/etiology
Antirheumatic Agents*/therapeutic use
Arthritis, Juvenile*/complications
Arthritis, Juvenile*/drug therapy
Arthritis, Juvenile*/epidemiology
Female ; Child ; Humans ; Male ; Cohort Studies ; Adrenal Cortex Hormones/therapeutic use ; Vision Disorders/drug therapy ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Patient groups in Rheumatoid arthritis identified by deep learning respond differently to biologic or targeted synthetic DMARDs.
Autorzy:
Kalweit M; Department of Computer Science, University of Freiburg, Freiburg, Germany.
Burden AM; ETH Zurich, Department of Chemistry and Applied Biosciences, Zurich, Switzerland.
Boedecker J; Department of Computer Science, University of Freiburg, Freiburg, Germany.
Hügle T; Department of Rheumatology, Lausanne University Hospital, and University of Lausanne, Lausanne, Switzerland.
Burkard T; ETH Zurich, Department of Chemistry and Applied Biosciences, Zurich, Switzerland.
Pokaż więcej
Źródło:
PLoS computational biology [PLoS Comput Biol] 2023 Jun 02; Vol. 19 (6), pp. e1011073. Date of Electronic Publication: 2023 Jun 02 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Deep Learning*
Antirheumatic Agents*/therapeutic use
Arthritis, Rheumatoid*/drug therapy
Biological Products*/therapeutic use
Humans ; Male ; Female ; Adalimumab/therapeutic use ; Prednisone/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A national, multicenter, retrospective study evaluating retention rate and efficacy of tocilizumab treatment in patients with active rheumatoid arthritis who had an inadequate response to csDMARDs and/or TNF inhibitors.
Autorzy:
İnanç GN; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Marmara University, İstanbul, Turkey.
Terzioğlu ME; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Akdeniz University, Antalya, Turkey.
Karabulut Y; Division of Rheumatology, Department of Internal Medicine, Doruk Yıldırım Hospital, Bursa, Turkey.
Yılmaz Z; Division of Rheumatology, Department of Internal Medicine, Tepecik Education and Research Hospital, Health Sciences University, İzmir, Turkey.
Tarhan EF; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Muğla Sıtkı Koçman University, Muğla, Turkey.
Enecik ME; Division of Rheumatology, Department of Internal Medicine, Medical Park Hospitals, Mersin, Turkey.
Şahin A; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Sivas Cumhuriyet University, Sivas, Turkey.
Küçük A; Division of Rheumatology, Department of Internal Medicine, Meram Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey.
Ayan A; Division of Rheumatology, Department of Internal Medicine, Antalya Training and Research Hospital, Antalya, Turkey.
Özgen M; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Ondokuz Mayıs University, Samsun, Turkey.
Karasu U; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Pamukkale University, Denizli, Turkey.
Yolbaş S; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, İnonü University, Malatya, Turkey.
Pokaż więcej
Źródło:
Turkish journal of medical sciences [Turk J Med Sci] 2023 Jun; Vol. 53 (3), pp. 731-743. Date of Electronic Publication: 2023 Jun 19.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Antirheumatic Agents*/therapeutic use
Arthritis, Rheumatoid*/drug therapy
Arthritis, Rheumatoid*/chemically induced
Humans ; Female ; Male ; Retrospective Studies ; Tumor Necrosis Factor Inhibitors/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Cost-utility analysis of biologic disease-modifying antirheumatic drugs (bDMARDs), targeted synthetic DMARDs (tsDMARDs) and biosimilar DMARDs (bsDMARDs) combined with methotrexate for Thai rheumatoid arthritis patients with high disease activity.
Autorzy:
Prawjaeng J; Siriraj Health Policy Unit, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.; Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Nonthaburi, Thailand.
Leelahavarong P; Siriraj Health Policy Unit, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. .; Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Nonthaburi, Thailand. .
Budtarad N; Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Nonthaburi, Thailand.; Siriraj Hospital, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Pilasant S; Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Nonthaburi, Thailand.; United States Agency for International Development (USAID) Regional Development Mission for Asia, Bangkok, Thailand.
Chanjam C; Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Nonthaburi, Thailand.; Puey Ungphakorn School of Development Studies, Thammasat University, 99 Moo 18 Paholyothin Road, Klong Nueng, Klong Luang, Pathumthani, Thailand.
Katchamart W; Division of Rheumatology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Narongroeknawin P; Division of Rheumatology, Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.
Kitumnuaypong T; Rheumatology Unit, Department of Medicine, Rajavithi Hospital, Bangkok, Thailand.
Pokaż więcej
Źródło:
BMC health services research [BMC Health Serv Res] 2023 May 31; Vol. 23 (1), pp. 561. Date of Electronic Publication: 2023 May 31.
Typ publikacji:
Meta-Analysis; Journal Article
MeSH Terms:
Antirheumatic Agents*/therapeutic use
Arthritis, Rheumatoid*/drug therapy
Biosimilar Pharmaceuticals*/therapeutic use
Humans ; Cost-Benefit Analysis ; Methotrexate/therapeutic use ; Quality of Life ; Southeast Asian People ; Network Meta-Analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Factors associated with subclinical inflammation of wrist joints in rheumatoid arthritis patients with low or no disease activity- a RA ultrasound registry study.
Autorzy:
Wang YW; Department of Rheumatology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, 123 Ta-Pei Road, Niao-Sung Dist. Kaohsiung 833, Kaohsiu, Taiwan.
Chen JF; Department of Rheumatology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, 123 Ta-Pei Road, Niao-Sung Dist. Kaohsiung 833, Kaohsiu, Taiwan.
Ko CH; Department of Rheumatology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, 123 Ta-Pei Road, Niao-Sung Dist. Kaohsiung 833, Kaohsiu, Taiwan.
Cheng TT; Department of Rheumatology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, 123 Ta-Pei Road, Niao-Sung Dist. Kaohsiung 833, Kaohsiu, Taiwan.
Chiu WC; Department of Rheumatology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, 123 Ta-Pei Road, Niao-Sung Dist. Kaohsiung 833, Kaohsiu, Taiwan.
Yu SF; Department of Rheumatology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, 123 Ta-Pei Road, Niao-Sung Dist. Kaohsiung 833, Kaohsiu, Taiwan.
Hsu CY; Department of Rheumatology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, 123 Ta-Pei Road, Niao-Sung Dist. Kaohsiung 833, Kaohsiu, Taiwan.
Chen YC; Department of Rheumatology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, 123 Ta-Pei Road, Niao-Sung Dist. Kaohsiung 833, Kaohsiu, Taiwan. .
Pokaż więcej
Źródło:
BMC musculoskeletal disorders [BMC Musculoskelet Disord] 2023 May 30; Vol. 24 (1), pp. 438. Date of Electronic Publication: 2023 May 30.
Typ publikacji:
Journal Article
MeSH Terms:
Arthritis, Rheumatoid*/diagnostic imaging
Arthritis, Rheumatoid*/drug therapy
Arthritis, Rheumatoid*/complications
Antirheumatic Agents*/therapeutic use
Synovitis*/diagnostic imaging
Synovitis*/drug therapy
Female ; Humans ; Male ; Middle Aged ; Aged ; Ultrasonography, Doppler ; Inflammation/diagnostic imaging ; Wrist Joint/diagnostic imaging ; Registries
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Increased risk of herpes zoster with tofacitinib treatment in Korean patients with rheumatoid arthritis: a single-center prospective study.
Autorzy:
Song YJ; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, 222-1 Wangsimni-ro, Seongdong-gu, Seoul, 04763, Republic of Korea.; Hanyang University Institute for Rheumatology Research, Seoul, Republic of Korea.
Cho SK; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, 222-1 Wangsimni-ro, Seongdong-gu, Seoul, 04763, Republic of Korea.; Hanyang University Institute for Rheumatology Research, Seoul, Republic of Korea.
Kim H; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, 222-1 Wangsimni-ro, Seongdong-gu, Seoul, 04763, Republic of Korea.; Hanyang University Institute for Rheumatology Research, Seoul, Republic of Korea.
Kim HW; Hanyang University Institute for Rheumatology Research, Seoul, Republic of Korea.
Nam E; Hanyang University Institute for Rheumatology Research, Seoul, Republic of Korea.
Jeon JY; Pfizer Pharmaceuticals Korea Ltd., Seoul, Republic of Korea.
Yoo HJ; Pfizer Pharmaceuticals Korea Ltd., Seoul, Republic of Korea.
Choi CB; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, 222-1 Wangsimni-ro, Seongdong-gu, Seoul, 04763, Republic of Korea.; Hanyang University Institute for Rheumatology Research, Seoul, Republic of Korea.
Kim TH; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, 222-1 Wangsimni-ro, Seongdong-gu, Seoul, 04763, Republic of Korea.; Hanyang University Institute for Rheumatology Research, Seoul, Republic of Korea.
Jun JB; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, 222-1 Wangsimni-ro, Seongdong-gu, Seoul, 04763, Republic of Korea.; Hanyang University Institute for Rheumatology Research, Seoul, Republic of Korea.
Bae SC; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, 222-1 Wangsimni-ro, Seongdong-gu, Seoul, 04763, Republic of Korea.; Hanyang University Institute for Rheumatology Research, Seoul, Republic of Korea.
Yoo DH; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, 222-1 Wangsimni-ro, Seongdong-gu, Seoul, 04763, Republic of Korea.; Hanyang University Institute for Rheumatology Research, Seoul, Republic of Korea.
Sung YK; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, 222-1 Wangsimni-ro, Seongdong-gu, Seoul, 04763, Republic of Korea. .; Hanyang University Institute for Rheumatology Research, Seoul, Republic of Korea. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 May 15; Vol. 13 (1), pp. 7877. Date of Electronic Publication: 2023 May 15.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antirheumatic Agents*/adverse effects
Arthritis, Rheumatoid*/epidemiology
Herpes Zoster*/chemically induced
Herpes Zoster*/epidemiology
Humans ; Prospective Studies ; Herpesvirus 3, Human ; Republic of Korea/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Nationwide patterns of hydroxychloroquine dosing and monitoring of retinal toxicity in patients with systemic lupus erythematosus.
Autorzy:
Lee JE; Department of Global Innovative Drugs and College of Pharmacy, Chung-Ang University, Seoul, 06974, Republic of Korea.
Nam DR; Department of Global Innovative Drugs and College of Pharmacy, Chung-Ang University, Seoul, 06974, Republic of Korea.
Sung YK; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, 04763, Republic of Korea.
Kim YJ; Department of Ophthalmology, Hanyang University Hospital, Seoul, 04763, Republic of Korea.
Jung SY; Department of Global Innovative Drugs and College of Pharmacy, Chung-Ang University, Seoul, 06974, Republic of Korea. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 May 04; Vol. 13 (1), pp. 7270. Date of Electronic Publication: 2023 May 04.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antirheumatic Agents*/adverse effects
Lupus Erythematosus, Systemic*/drug therapy
Retinal Diseases*/chemically induced
Retinal Diseases*/epidemiology
Retinal Diseases*/diagnosis
Humans ; Hydroxychloroquine/adverse effects ; Body Weight
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
"From Where I Stand": using multiple anchors yields different benchmarks for meaningful improvement and worsening in the rheumatoid arthritis flare questionnaire (RA-FQ).
Autorzy:
Bartlett SJ; Centre for Outcomes Research and Evaluation, McGill University, 5252 de Maisonneuve, #3D.57, Montreal, QC, H4A 3S5, Canada. .; Research Institute, McGill University Health Center, Montreal, QC, Canada. .; Arthritis Research Canada, Vancouver, Canada. .
Bykerk VP; Hospital for Special Surgery, Weill Cornell Medical College, New York, NY, USA.
Schieir O; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Valois MF; Centre for Outcomes Research and Evaluation, McGill University, 5252 de Maisonneuve, #3D.57, Montreal, QC, H4A 3S5, Canada.
Pope JE; St. Joseph's Health Care London, University of Western Ontario, London, ON, Canada.
Boire G; University of Sherbrooke, Sherbrooke, QC, Canada.
Hitchon C; University of Manitoba, Winnipeg, MB, Canada.
Hazlewood G; Arthritis Research Canada, Vancouver, Canada.; University of Calgary, Calgary, AB, Canada.
Bessette L; University of Laval, Quebec City, QC, Canada.
Keystone E; Mount Sinai Hopsital, Toronto, ON, Canada.
Thorne C; The Arthritis Center, Newmarket, ON, Canada.
Tin D; The Arthritis Center, Newmarket, ON, Canada.
Bingham CO 3rd; Johns Hopkins Medicine, Baltimore, MD, USA.
Pokaż więcej
Corporate Authors:
CATCH Investigators
Źródło:
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [Qual Life Res] 2023 May; Vol. 32 (5), pp. 1307-1318. Date of Electronic Publication: 2022 Sep 08.
Typ publikacji:
Journal Article
MeSH Terms:
Arthritis, Rheumatoid*
Antirheumatic Agents*/therapeutic use
Adult ; Humans ; Female ; Middle Aged ; Male ; Benchmarking ; Canada ; Quality of Life/psychology ; Surveys and Questionnaires ; Severity of Illness Index
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Integrating Nanotechnological Advancements of Disease-Modifying Anti-Rheumatic Drugs into Rheumatoid Arthritis Management.
Autorzy:
Singh, Sukhbir (AUTHOR)
Tiwary, Neha (AUTHOR)
Sharma, Neelam (AUTHOR)
Behl, Tapan (AUTHOR)
Antil, Anita (AUTHOR)
Anwer, Md. Khalid (AUTHOR)
Ramniwas, Seema (AUTHOR)
Sachdeva, Monika (AUTHOR)
Elossaily, Gehan M. (AUTHOR)
Gulati, Monica (AUTHOR)
Ohja, Shreesh (AUTHOR)
Pokaż więcej
Źródło:
Pharmaceuticals (14248247). Feb2024, Vol. 17 Issue 2, p248. 19p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Decision Impact Analysis to Measure the Influence of Molecular Signature Response Classifier Testing on Treatment Selection in Rheumatoid Arthritis.
Autorzy:
Curtis, Jeffrey R. (AUTHOR)
Strand, Vibeke (AUTHOR)
Golombek, Steven J. (AUTHOR)
Karpouzas, George A. (AUTHOR)
Zhang, Lixia (AUTHOR)
Wong, Angus (AUTHOR)
Patel, Krishna (AUTHOR)
Dines, Jennifer (AUTHOR)
Akmaev, Viatcheslav R. (AUTHOR)
Pokaż więcej
Źródło:
Rheumatology & Therapy. Feb2024, Vol. 11 Issue 1, p61-77. 17p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Transcriptomic profiling of programmed cell death 1 (PD-1) expressing T cells in early rheumatoid arthritis identifies a decreased CD4 + PD-1 + signature post-treatment.
Autorzy:
Lowe K; Rheumatology Synovial Tissue Translational Research Group, Flinders University, Adelaide, South Australia, 5042, Australia.
Small A; Rheumatology Synovial Tissue Translational Research Group, Flinders University, Adelaide, South Australia, 5042, Australia.
Song Q; Discovery Immunology Janssen R&D, 1400 McKean Road, Spring House, PA, 19477, USA.
Hao LY; Discovery Immunology Janssen R&D, 1400 McKean Road, Spring House, PA, 19477, USA.
Murray-Brown W; Rheumatology Synovial Tissue Translational Research Group, Flinders University, Adelaide, South Australia, 5042, Australia.
Proudman S; Department of Rheumatology, Royal Adelaide Hospital, Adelaide, Australia.; Discipline of Medicine, University of Adelaide, Adelaide, Australia.
Smith MD; Rheumatology Synovial Tissue Translational Research Group, Flinders University, Adelaide, South Australia, 5042, Australia.
Nagpal S; Discovery Immunology Janssen R&D, 1400 McKean Road, Spring House, PA, 19477, USA.
Wechalekar MD; Rheumatology Synovial Tissue Translational Research Group, Flinders University, Adelaide, South Australia, 5042, Australia. .; Department of Rheumatology, Flinders Medical Centre, Adelaide, South Australia, 5042, Australia. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Feb 17; Vol. 13 (1), pp. 2847. Date of Electronic Publication: 2023 Feb 17.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Arthritis, Rheumatoid*/drug therapy
Arthritis, Rheumatoid*/genetics
Antirheumatic Agents*/pharmacology
Antirheumatic Agents*/therapeutic use
Antirheumatic Agents*/metabolism
Humans ; CD4-Positive T-Lymphocytes ; Transcriptome ; Programmed Cell Death 1 Receptor/genetics ; Programmed Cell Death 1 Receptor/metabolism ; Apoptosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Xanthones from securidaca inappendiculata antagonizes the anti-rheumatic effect of methotrexate by inhibiting reduced folate carrier 1.
Autorzy:
Zhang SS; Department of Pharmacy, The Second Affiliated Hospital of Wannan Medical College, Wuhu, China.
Wu YJ; Department of Pharmacy, The Second Affiliated Hospital of Wannan Medical College, Wuhu, China.; Department of Traditional Chinese Medicine, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital), Wuhu, China.
Pan S; Department of Pharmacy, The Second Affiliated Hospital of Wannan Medical College, Wuhu, China.
Wang QH; School of Pharmacy, Anhui College of Traditional Chinese Medicine, Wuhu, Anhui, China.
Chen WG; Department of Pharmacy, The Second Affiliated Hospital of Wannan Medical College, Wuhu, China.
Wang ZF; Department of Pharmacy, The Second Affiliated Hospital of Wannan Medical College, Wuhu, China.
Xu JY; Department of Pharmacy, The Second Affiliated Hospital of Wannan Medical College, Wuhu, China.
Zuo J; Department of Traditional Chinese Medicine, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital), Wuhu, China.; Research Center of Integration of Traditional Chinese and Western Medicine, Wannan Medical College, Wuhu, China.; Key Laboratory of Non-coding RNA Transformation Research of Anhui Higher Education Institution, Wannan Medical College, Wuhu, China.
Yin Q; Department of Pharmacy, The Second Affiliated Hospital of Wannan Medical College, Wuhu, China.
Pokaż więcej
Źródło:
Immunopharmacology and immunotoxicology [Immunopharmacol Immunotoxicol] 2023 Feb; Vol. 45 (1), pp. 16-25. Date of Electronic Publication: 2022 Aug 01.
Typ publikacji:
Journal Article
MeSH Terms:
Securidaca*/metabolism
Antirheumatic Agents*/pharmacology
Antirheumatic Agents*/therapeutic use
Xanthones*/pharmacology
Rats ; Animals ; Methotrexate/pharmacology ; Reduced Folate Carrier Protein
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The feasibility of existing JADAS10 cut-off values in clinical practice: a study of data from The Finnish Rheumatology Quality Register.
Autorzy:
Backström M; Department of Paediatrics, The Wellbeing Services County of Ostrobothnia, Vaasa, Finland. .; PEDEGO Research Unit, University of Oulu, Oulu, Finland. .; Vaasa Central Hospital, U2, Hietalahdenkatu 2-4, 65130, Vaasa, Finland. .
Salo H; Knowledge Brokers Department, Finnish Institute for Health and Welfare, Helsinki, Finland.
Kärki J; Department of Children and Adolescents, Kanta-Häme Central Hospital, Hämeenlinna, Finland.; The Finnish Institute for Welfare and Health, The Finnish Rheumatology Quality Register, Helsinki, Finland.
Aalto K; New Children's Hospital, Pediatric Research Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Rebane K; New Children's Hospital, Pediatric Research Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Levälampi T; New Children's Hospital, Pediatric Research Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Grönlund MM; Department of Paediatrics, Turku University Hospital, Turku, Finland.
Kröger L; Department of Children and Adolescents, Kuopio University Hospital, Kuopio, Finland.
Pohjankoski H; Department of Children and Adolescents, Päijät-Häme Central Hospital, Lahti, Finland.
Hietanen M; Department of Children and Adolescents, Päijät-Häme Central Hospital, Lahti, Finland.
Korkatti K; Department of Paediatrics, Central Ostrobothnia Central Hospital, Kokkola, Finland.
Kuusalo L; Centre for Rheumatology and Clinical Immunology, Division of Medicine, University of Turku and Turku University Hospital, Turku, Finland.
Rantalaiho V; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Centre for Rheumatic Diseases, Tampere University Hospital, Tampere, Finland.; Centre for Rheumatic Diseases, Kanta-Häme Central Hospital, Hämeenlinna, Finland.
Huhtakangas J; Division of Rheumatology, Kuopio University Hospital, Kuopio, Finland.
Relas H; Department of Rheumatology, Inflammation Center, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland.
Pääkkö T; Department of Internal Medicine, Oulu University Hospital, Oulu, Finland.
Löyttyniemi E; Department of Biostatistics, University of Turku, Turku, Finland.
Sokka-Isler T; University of Eastern Finland, Kuopio and Central Finland Central Hospital, Jyväskylä, Finland.
Vähäsalo P; PEDEGO Research Unit, University of Oulu, Oulu, Finland.; Department of Paediatrics, Oulu University Hospital, Oulu, Finland.; Medical Research Center, Oulu University Hospital and University of Oulu, Oulu, Finland.
Pokaż więcej
Źródło:
Pediatric rheumatology online journal [Pediatr Rheumatol Online J] 2023 Apr 14; Vol. 21 (1), pp. 35. Date of Electronic Publication: 2023 Apr 14.
Typ publikacji:
Journal Article
MeSH Terms:
Arthritis, Juvenile*/diagnosis
Arthritis, Juvenile*/drug therapy
Antirheumatic Agents*/therapeutic use
Rheumatology*
Humans ; Finland ; Feasibility Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Immunogenicity and Safety of Adjuvanted Recombinant Zoster Vaccine in Rheumatoid Arthritis Patients on Anti-Cellular Biologic Agents or JAK Inhibitors: A Prospective Observational Study.
Autorzy:
Venerito V; Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Polyclinic Hospital, University of Bari, 70124 Bari, Italy.
Stefanizzi P; Interdisciplinary Department of Medicine, Aldo Moro University of Bari, 70121 Bari, Italy.
Cantarini L; Department of Medical Sciences, Surgery and Neurosciences, Research Center of Systemic Autoinflammatory Diseases and Behçet's Disease Clinic, University of Siena, 53100 Siena, Italy.
Lavista M; Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Polyclinic Hospital, University of Bari, 70124 Bari, Italy.
Galeone MG; Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Polyclinic Hospital, University of Bari, 70124 Bari, Italy.
Di Lorenzo A; Interdisciplinary Department of Medicine, Aldo Moro University of Bari, 70121 Bari, Italy.
Iannone F; Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Polyclinic Hospital, University of Bari, 70124 Bari, Italy.
Tafuri S; Interdisciplinary Department of Medicine, Aldo Moro University of Bari, 70121 Bari, Italy.
Lopalco G; Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Polyclinic Hospital, University of Bari, 70124 Bari, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Apr 09; Vol. 24 (8). Date of Electronic Publication: 2023 Apr 09.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Antirheumatic Agents*/therapeutic use
Arthritis, Rheumatoid*/drug therapy
Herpes Zoster*/prevention & control
Herpes Zoster Vaccine*/adverse effects
Janus Kinase Inhibitors*/therapeutic use
Aged ; Female ; Humans ; Middle Aged ; Adjuvants, Immunologic/therapeutic use ; Biological Factors/therapeutic use ; Immunoglobulin G/blood ; Prospective Studies ; Immunogenicity, Vaccine
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 41-60 z 10174

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies